Progress in Antidiabetic Effects of Sesquiterpenoids

doi:10.21127/yaoyimr20230009

Abstract

Abstract: Sesquiterpenoids have a wide range of physiological activities, and have potent effects against various diseases. In recent years, many sesquiterpenoids have been reported to show significant bioactivities on diabetes mellitus that is an increasingly severe metabolic disease. In this paper, the bioactivities of sesquiterpenoids on diabetes mellitus in the past twenty years are reviewed.

Key words: diabetes mellitus, sesquiterpenoids, bioactivity, metabolic disease

Kunyi Zhang, Yi Liu, Feixiang Guo, Huiqin Zheng, Qianqian Sun, Lizhen Fang. Progress in Antidiabetic Effects of Sesquiterpenoids[J]. Medicine Research, 2023, 7(3-4): 230009-230009.

References

[1] Choudhury H.; Pandey M.; Hua C. K.; Mun C. S.; Jing J. K.; Kong L.; Ern L. Y.; Ashraf N. A.; Kit S. W.; Yee T. S.; Pichika M. R.; Gorain B.; Kesharwani P.An update on natural compounds in the remedy of diabetes mellitus: A systematic review. [J]. Tradit. Complement. Med. 2018, 8, 361-376.
[2] American Diabetes, A. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37, S81-S90.
[3] Maurya A.; Mohan S.; Verma S. C.Antidiabetic Potential of Naturally Occurring Sesquiterpenes: A Review. Curr. Top Med. Chem. 2021, 21, 851-862.
[4] Ren Y.; Li L.; Wan L.; Huang Y.; Cao S.Glucokinase as an emerging anti-diabetes target and recent progress in the development of its agonists. [J]. Enzyme Inhib. Med. Chem. 2022, 37, 606-615.
[5] Al Kury, L. T.; Abdoh, A.; Ikbariah, K.; Sadek, B.; Mahgoub, M. In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An Update. Molecules 2021, 27, 182-210.
[6] Park K.; Lee B. M.; Kim Y. H.; Han T.; Yi W.; Lee D. H.; Choi H. H.; Chong W.; Lee C. H.Discovery of a novel phenylethyl benzamide glucokinase activator for the treatment of type 2 diabetes mellitus. Bioorg. Med. Chem. Lett. 2013, 23, 537-542.
[7] Chen L.; Lu X.; El-Seedi, H.; Teng, H. Recent advances in the development of sesquiterpenoids in the treatment of type 2 diabetes. Trends Food Sci. Technol. 2019, 88, 46-56.
[8] Hou C.-C.; Lin S.-J.; Cheng J.-T.; Hsu F.-L.Antidiabetic Dimeric Guianolides and a Lignan Glycoside from Lactuca indica. [J]. Nat. Prod. 2003, 66, 625-629.
[9] Nishiyama T.; Mae T.; Kishida H.; Tsukagawa M.; Mimaki Y.; Kuroda M.; Sashida Y.; Takahashi K.; Kawada T.; Nakagawa K.; Kitahara M.Curcuminoids and Sesquiterpenoids in Turmeric (Curcuma longa L.) Suppress an Increase in Blood Glucose Level in Type 2 Diabetic KK-Ay Mice. J. Agric. Food Chem. 2005, 53, 959-963.
[10] Al-Amin,Z. M.; Thomson, M.; Al-Qattan, K. K.; Peltonen- Shalaby, R.; Ali, M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br. J. Nutr. 2006, 96, 660-666.
[11] Akhani S. P.; Vishwakarma S. L.; Goyal R. K.Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. [J]. Pharm. Pharmacol. 2004, 56, 101-105.
[12] Byon J. C.H.; Kusari, A. B.; Kusari, J. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Mol. Cell. Biochem. 1998, 182, 101-108.
[13] Huang X.-C.; Li J.; Li Z.-Y.; Shi L.; Guo Y.-W.Sesquiterpenes from the Hainan Sponge Dysidea septosa. [J]. Nat. Prod. 2008, 71, 1399-1403.
[14] Li Y.; Zhang Y.; Shen X.; Guo Y.-W.A novel sesquiterpene quinone from Hainan sponge Dysidea villosa. Bioorg. Med. Chem. Lett. 2009, 19, 390-392.
[15] Chen J.; Li W. L.; Wu J. L.; Ren B. R.; Zhang H. Q.Hypoglycemic effects of a sesquiterpene glycoside isolated from leaves of loquat (Eriobotrya japonica (Thunb.) Lindl.). Phytomedicine 2008, 15, 98-102.
[16] Kim D. Y.; Choi B. Y.Costunolide-A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential. Int. [J]. Mol. Sci. 2019, 20, 2926-2942.
[17] Eliza J.; Daisy P.; Ignacimuthu S.; Duraipandiyan V.Normo-glycemic and hypolipidemic effect of costunolide isolated from Costus speciosus (Koen ex. Retz.)Sm. in streptozotocin-induced diabetic rats. Chem. Biol. Interact. 2009, 179, 329-334.
[18] Eliza J.; Daisy P.; Ignacimuthu S.Antioxidant activity of costunolide and eremanthin isolated from Costus speciosus (Koen ex. Retz) Sm. Chem. Biol. Interact. 2010, 188, 467-472.
[19] Inoue A.; Tamogami S.; Kato H.; Nakazato Y.; Akiyama M.; Kodama O.; Akatsuka T.; Hashidoko Y.Antifungal melampolides from leaf extracts of Smallanthus sonchifolius. Phytochemistry 1995, 39, 845-848.
[20] Genta S. B.; Cabrera W. M.; Mercado M. I.; Grau A.; Catalan C. A.; Sanchez S. S.Hypoglycemic activity of leaf organic extracts from Smallanthus sonchifolius: Constituents of the most active fractions. Chem. Biol. Interact. 2010, 185, 143-152.
[21] Yende S.; Harle U.; Rajgure D.; Tuse T.; Vyawahare N.Pharmacological profile of Acorus calamus: An Overview'. Pharm. Rev. 2008, 2, 22-26.
[22] Raja A. E.; Vijayalakshmi M.; Devalarao G.Acorus calamus Linn.: chemistry and biology. Res. [J]. Pharm. Technol. 2009, 2, 256-261.
[23] Si M. M.; Lou J. S.; Zhou C. X.; Shen J. N.; Wu H. H.; Yang B.; He Q. J.; Wu H. S.Insulin releasing and alpha- glucosidase inhibitory activity of ethyl acetate fraction of Acorus calamus in vitro and in vivo. [J]. Ethnopharmacol. 2010, 128, 154-159.
[24] Wu H. S.; Zhu D. F.; Zhou C. X.; Feng C. R.; Lou Y. J.; Yang B.; He Q. J.Insulin sensitizing activity of ethyl acetate fraction of Acorus calamus L. in vitro and in vivo. [J]. Ethnopharm. 2009, 123, 288-292.
[25] Zhou C. X.; Qiao D.; Yan Y. Y.; Wu H. S.; Mo J. X.; Gan L. S.A new anti-diabetic sesquiterpenoid from Acorus calamus. Chin. Chem. Lett. 2012, 23, 1165-1168.
[26] Chao C. L.; Huang H. C.; Lin H. C.; Chang T. C.; Chang W. L.Sesquiterpenes from Baizhu Stimulate Glucose Uptake by Activating AMPK and PI3K. Am. [J]. Chin. Med. 2016, 44, 963-979.
[27] Kim C. K.; Kim M.; Oh S. D.; Lee S. M.; Sun B.; Choi G. S.; Kim S. K.; Bae H.; Kang C.; Min B. I.Effects of Atractylodes macrocephala Koidzumi rhizome on 3T3-L1 adipogenesis and an animal model of obesity. [J]. Ethnopharm. 2011, 137, 396-402.
[28] Li C. Q.; He L. C.; Dong H. Y.; Jin J. Q.Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz. [J]. Ethnopharm. 2007, 114, 212-217.
[29] Fu X. Q.; Chou G. X.; Kwan H. Y.; Tse A. K.; Zhao L. H.; Yuen T. K.; Cao H. H.; Yu H.; Chao X. J.; Su T.; Cheng B. C.; Sun X. G.; Yu Z. L.Inhibition of STAT3 signalling contributes to the antimelanoma action of atractylenolide II. Exp. Dermatol. 2014, 23, 855-857.
[30] Hardie D. G.; Ross F. A.; Hawley S. A.AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012, 13, 251-262.
[31] Eliza J.; Daisy P.; Ignacimuthu S.; Duraipandiyan V.Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.)Sm., in STZ-induced diabetic rats. Chem. Biol. Interact. 2009, 182, 67-72.
[32] Basha R. H.;Sankaranarayanan, C. beta-Caryophyllene, a natural sesquiterpene, modulates carbohydrate metabolism in streptozotocin-induced diabetic rats. Acta Histochem. 2014, 116, 1469-1479.
[33] Dewanjee S.; Das A. K.; Sahu R.; Gangopadhyay M.Antidiabetic activity of Diospyros peregrina fruit: Effect on hyperglycemia, hyperlipidemia and augmented oxidative stress in experimental type 2 diabetes. Food Chem. Toxicol. 2009, 47, 2679-2685.
[34] Giacco F.; Brownlee M.Oxidative stress and diabetic complications. Circ. Res. 2010, 107, 1058-1070.
[35] Matheus A.S. d. M.; Tannus, L. R. M.; Cobas, R. A.; Palma, C. C. S.; Negrato, C. A.; Gomes, M. d. B. Impact of Diabetes on Cardiovascular Disease: An Update. Int. [J]. Hypertension 2013, 2013, 653789.
[36] Basha R. H.;Sankaranarayanan, C. beta-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats. Chem. Biol. Interact. 2016, 245, 50-58.